You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BTK (Brutons tyrosine kinase)

Showing 1 - 25 of 2,353
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

Recruiting
  • Atrial Fibrillation
  • +4 more
  • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
  • New Hyde Park, New York
    Northwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022

Safety and Tolerability, Compare SHINGRIX Vaccine Response Rates, Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI

Active, not recruiting
Has Results
  • Safety and Tolerability
  • +3 more
  • Zoster Vaccine Recombinant, Adjuvanted
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 10, 2022

Hepatitis, Safety and Tolerability Trial run by the NHLBI (HEPLISAV-B)

Completed
Has Results
  • Hepatitis
  • Safety and Tolerability
  • HEPLISAV-B
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 13, 2022

Neuromyelitis Optica Trial in Beijing (zanubrutinib)

Recruiting
  • Neuromyelitis Optica
  • Beijing, Beijing, China
    XuanWu Hospital
May 15, 2022

Waldenstrom Macroglobulinemia Trial (Zanubrutinib)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • (no location specified)
Nov 28, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
  • +11 more
Nov 23, 2022

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,

Active, not recruiting
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +9 more
  • BTK inhibitor PCI-32765
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 27, 2022

GVHD Trial in Japan (Ibrutinib)

Completed
  • Graft vs Host Disease
  • Anjo-shi, Japan
  • +14 more
Dec 30, 2021

Healthy Volunteer Trial in Dallas (BIIB091, Placebo)

Completed
  • Healthy Volunteer
  • Dallas, Texas
    Research Site
Mar 19, 2021

Waldenstrom Macroglobulinemia Trial in China (Ibrutinib)

Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • Changchun, China
  • +5 more
Jan 27, 2023

Waldenstrom Macroglobulinemia Trial in Japan (Ibrutinib, Rituximab)

Active, not recruiting
Has Results
  • Waldenstrom Macroglobulinemia
  • Chiba, Japan
  • +8 more
Jan 27, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Acalabrutinib, Obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Waldenström's Macroglobulinemia (WM) Trial in China (Zanubrutinib)

Completed
Has Results
  • Waldenström's Macroglobulinemia (WM)
  • Beijing, Beijing, China
  • +10 more
Mar 7, 2022

Multiple Myeloma Trial in Canada, United States (Ibrutinib, Carfilzomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Duarte, California
  • +16 more
Nov 24, 2021

Atrial Fibrillation Trial in Caen (Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®))

Not yet recruiting
  • Atrial Fibrillation
  • Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®)
  • Caen, Normandie, France
    Caen University Hospital, Department of Pharmacology
Sep 6, 2023

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +7 more
  • Manchester, United Kingdom
  • +2 more
Aug 11, 2022

Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib, Ublituximab, Umbralisib)

Suspended
  • Mantle Cell Lymphoma
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Mantle Cell Lymphoma Trial in Hackensack (Lenalidomide, Ibrutinib, Rituximab)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Hackensack, New Jersey
    The Cancer Center at Hackensack University Medical Center
May 3, 2022

Diffuse Large B-cell Lymphoma Trial in China (Zanubrutinib)

Completed
Has Results
  • Diffuse Large B-cell Lymphoma
  • Beijing, Beijing, China
  • +10 more
Oct 11, 2021

Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • B-Cell Lymphoproliferative Disorder
  • Boston, Massachusetts
  • +2 more
Feb 18, 2023

Primary Membranous Nephropathy Trial (EVER001)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
Mar 23, 2023

Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt

Active, not recruiting
  • Prolymphocytic Leukemia
  • +4 more
  • Columbus, Ohio
  • +1 more
Apr 29, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide

Completed
Has Results
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +2 more
  • Tafasitamab
  • +2 more
  • Jacksonville, Florida
  • +16 more
Dec 10, 2021

r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

Not yet recruiting
  • B-cell Lymphoma
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Aug 9, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Duarte, California
  • +10 more
Jul 14, 2022